{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:05:32Z","timestamp":1791317132404,"version":"4.3.1"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00071","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:24:56Z","timestamp":1552623896000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":125,"title":["Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases"],"prefix":"10.3389","volume":"7","author":[{"given":"Wook Youn","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne A.","family":"Montes-Mojarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B3","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood","volume-title":"Who Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Quintanilla-Martinez","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/07853890500465189","article-title":"Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives","volume":"38","author":"Verbsky","year":"2006","journal-title":"Ann Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3201\/eid0606.000608","article-title":"Hemophagocytic syndromes and infection","volume":"6","author":"Fisman","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1182\/asheducation-2015.1.177","article-title":"Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis","volume":"2015","author":"Allen","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn","year":"2018","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26264","article-title":"Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: a retrospective multicenter study","volume":"64","author":"Xu","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3389\/fimmu.2017.01902","article-title":"Epstein-Barr virus and hemophagocytic lymphohistiocytosis","volume":"8","author":"Marsh","year":"2017","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","article-title":"Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"44","author":"Imashuku","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fped.2016.00047","article-title":"Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment","volume":"4","author":"Ishii","year":"2016","journal-title":"Front Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/apm.12308","article-title":"Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia","volume":"123","author":"Min","year":"2015","journal-title":"APMIS"},{"key":"B16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1040-8428(02)00119-1","article-title":"Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection","volume":"44","author":"Kasahara","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.4049\/jimmunol.170.12.5993","article-title":"Acquisition of viral receptor by NK cells through immunological synapse","volume":"170","author":"Tabiasco","year":"2003","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.cca.2011.04.036","article-title":"Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis","volume":"412","author":"Matsuda","year":"2011","journal-title":"Clin Chim Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13\u20134 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18\u20132 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am J Hum Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.0105-2896.2010.00896.x","article-title":"Perforin: structure, function, and role in human immunopathology","volume":"235","author":"Voskoboinik","year":"2010","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/eji.201646885","article-title":"Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients","volume":"47","author":"Meazza","year":"2017","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","article-title":"SLAM family receptors and SAP adaptors in immunity","volume":"29","author":"Cannons","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","article-title":"XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation","volume":"7","author":"Yabal","year":"2014","journal-title":"Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/emmm.201303090","article-title":"Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling","volume":"5","author":"Damgaard","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/infdis\/157.3.405","article-title":"The chronic mononucleosis syndrome","volume":"157","author":"Straus","year":"1988","journal-title":"J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev.me.38.020187.001211","article-title":"Chronic Epstein-Barr virus infection","volume":"38","author":"Jones","year":"1987","journal-title":"Annu Rev Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev Med Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4132\/KoreanJPathol.2013.47.2.137","article-title":"EBV-positive T\/NK-cell lymphoproliferative disease of childhood","volume":"47","author":"Hong","year":"2013","journal-title":"Korean J Pathol"},{"key":"B36","first-page":"2430","article-title":"Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.inf.0000154335.48682.af","article-title":"Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease","volume":"24","author":"Roth","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jclinpath-2011-200523","article-title":"T\/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T\/NK-cell lymphoma","volume":"65","author":"Isobe","year":"2012","journal-title":"J Clin Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"B40","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.4049\/jimmunol.134.5.3082","article-title":"Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis)","volume":"134","author":"Tosato","year":"1985","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jmv.1029","article-title":"Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection","volume":"64","author":"Tsuge","year":"2001","journal-title":"J Med Virol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/423285","article-title":"Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection","volume":"190","author":"Sugaya","year":"2004","journal-title":"J Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","article-title":"Hydroa vacciniforme: a clinical and follow-up study of 17 cases","volume":"42","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0190-9622(95)90181-7","article-title":"Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential","volume":"32","author":"Ruiz-Maldonado","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":"Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","article-title":"The association of latent Epstein-Barr virus infection with hydroa vacciniforme","volume":"140","author":"Iwatsuki","year":"1999","journal-title":"Br J Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0190-9622(99)70210-0","article-title":"Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy","volume":"40","author":"Iwatsuki","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0190-9622(98)70120-3","article-title":"Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma","volume":"38","author":"Magana","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","article-title":"Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases","volume":"151","author":"Cho","year":"2004","journal-title":"Br J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23838\/pfm.2017.00198","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative diseases in children and adolescents","volume":"2","author":"Ko","year":"2018","journal-title":"Precis Future Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1097\/PAS.0b013e3181fbb4fd","article-title":"EBV-associated cutaneous NK\/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults","volume":"34","author":"Rodriguez-Pinilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/jid.2011.461","article-title":"Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected gammadeltaT cells","volume":"132","author":"Hirai","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12185-012-1156-0","article-title":"Clonal expansion of Epstein-Barr virus (EBV)-infected gammadelta T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions","volume":"96","author":"Wada","year":"2012","journal-title":"Int J Hematol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1099\/vir.0.013482-0","article-title":"Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection","volume":"91","author":"Iwata","year":"2010","journal-title":"J Gen Virol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S","article-title":"Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites","volume":"54","author":"Ishihara","year":"1997","journal-title":"Am J Hematol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1349-7006.1997.tb00305.x","article-title":"Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells","volume":"88","author":"Ishihara","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archderm.1990.01670270094016","article-title":"Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis","volume":"126","author":"Tokura","year":"1990","journal-title":"Arch Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.jinf.2005.08.035","article-title":"Epstein-Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite","volume":"52","author":"Cho","year":"2006","journal-title":"J Infect"},{"key":"B65","first-page":"420","article-title":"Hypersensitivity to mosquito bite: a case report","volume":"11","author":"Fan","year":"1995","journal-title":"Gaoxiong Yi Xue Ke Xue Za Zhi"},{"key":"B66","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1067\/mjd.2001.114751","article-title":"Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia\/lymphoma","volume":"45","author":"Tokura","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.0022-202X.2005.23915.x","article-title":"Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites","volume":"125","author":"Asada","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1349-7006.2005.00076.x","article-title":"Enhanced T-cell response to mosquito extracts by NK cells in hypersensitivity to mosquito bites associated with EBV infection and NK cell lymphocytosis","volume":"96","author":"Tokura","year":"2005","journal-title":"Cancer Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/archderm.139.12.1601","article-title":"CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis","volume":"139","author":"Asada","year":"2003","journal-title":"Arch Dermatol"},{"key":"B70","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V82.11.3259.3259","article-title":"Fatal Epstein-Barr virus-associated hemophagocytic syndrome","volume":"82","author":"Kikuta","year":"1993","journal-title":"Blood"},{"key":"B71","first-page":"1219","article-title":"Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan","volume":"144","author":"Su","year":"1994","journal-title":"Am J Pathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3892\/ijo.24.5.1165","article-title":"Clinicopathological states of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults","volume":"24","author":"Suzuki","year":"2004","journal-title":"Int J Oncol"},{"key":"B73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443.014k32_443_451","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"B74","first-page":"185","article-title":"Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy","volume":"1","author":"Young","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"B75","first-page":"565","article-title":"Virally associated T-cell and NK-cell neoplasms","volume-title":"Haematopathology","author":"Ko","year":"2016"},{"key":"B76","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM198803243181203","article-title":"T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections","volume":"318","author":"Jones","year":"1988","journal-title":"N Engl J Med"},{"key":"B77","first-page":"5738","article-title":"The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder","volume":"7","author":"Smith","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2141.1990.tb02615.x","article-title":"Aggressive natural killer cell leukaemia\/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells","volume":"75","author":"Imamura","year":"1990","journal-title":"Br J Haematol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1046\/j.1365-2559.2000.01029.x","article-title":"Commentary: aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies","volume":"37","author":"Quintanilla-Martinez","year":"2000","journal-title":"Histopathology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1080\/10428190400004513","article-title":"Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature","volume":"45","author":"Ruskova","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1365-2141.1998.01095.x","article-title":"Elevated serum soluble Fas ligand in natural killer cell proliferative disorders","volume":"103","author":"Kato","year":"1998","journal-title":"Br J Haematol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia"},{"key":"B83","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"B84","first-page":"782","article-title":"Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders","volume":"7","author":"Oshimi","year":"1993","journal-title":"Leukemia"},{"key":"B85","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2141.1994.tb04804.x","article-title":"Aggressive natural killer cell leukaemia\/lymphoma in two patients with lethal midline granuloma","volume":"86","author":"Soler","year":"1994","journal-title":"Br J Haematol"},{"key":"B86","first-page":"3423","article-title":"Six cases of aggressive natural killer-cell leukemia in a Chinese population","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/modpathol.2017.37","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: a clinical and pathological study from a single institution","volume":"30","author":"Gao","year":"2017","journal-title":"Mod Pathol"},{"key":"B88","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1182\/blood.V79.8.2116.2116","article-title":"Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells","volume":"79","author":"Hart","year":"1992","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1172\/JCI114168","article-title":"CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA","volume":"84","author":"Kawa-Ha","year":"1989","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features","volume":"41","author":"Nicolae","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/1346-8138.12322","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders","volume":"41","author":"Park","year":"2014","journal-title":"J Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"B94","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/PAS.0000000000000634","article-title":"Clinicopathologic characterization of aggressive natural killer cell leukemia involving different tissue sites","volume":"40","author":"Gao","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B95","first-page":"368","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","volume-title":"Who Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan","year":"2017"},{"key":"B96","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/00313028609087562","article-title":"Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese. a study of 75 cases in Hong Kong","volume":"18","author":"Ng","year":"1986","journal-title":"Pathology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ijc.2910440112","article-title":"Nation-wide study of lethal mid-line granuloma in Japan: frequencies of wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions","volume":"44","author":"Aozasa","year":"1989","journal-title":"Int J Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4132\/KoreanJPathol.2011.45.3.254","article-title":"WHO Classification of malignant lymphomas in Korea: report of the third nationwide study","volume":"45","author":"Kim","year":"2011","journal-title":"J Pathol Transl Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0046-8177(99)90147-8","article-title":"Histological and immunophenotypic profile of nasal NK\/T cell lymphomas from Peru: high prevalence of p53 overexpression","volume":"30","author":"Quintanilla-Martinez","year":"1999","journal-title":"Hum Pathol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the international peripheral T-cell lymphoma project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1111\/j.1349-7006.2009.01319.x","article-title":"Extranodal NK \/ T-cell lymphoma, nasal type: new staging system and treatment strategies","volume":"100","author":"Kim","year":"2009","journal-title":"Cancer Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0609.2007.00978.x","article-title":"Comparative analysis of extra-nodal NK\/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis","volume":"80","author":"Lim","year":"2008","journal-title":"Eur J Haematol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/1471-2407-14-890","article-title":"CD30 expression is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3109\/10428194.2014.974048","article-title":"Prognostic implications of CD30 expression in extranodal natural killer\/T-cell lymphoma according to treatment modalities","volume":"56","author":"Kim","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B105","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD anderson cancer center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.humpath.2014.11.008","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors","volume":"46","author":"Jhuang","year":"2015","journal-title":"Hum Pathol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/annonc\/mdp056","article-title":"Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK\/T-cell lymphoma","volume":"20","author":"Kim","year":"2009","journal-title":"Ann Oncol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00428-016-2011-0","article-title":"Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK\/T cell lymphoma is associated with better prognosis","volume":"469","author":"Kim","year":"2016","journal-title":"Virchows Arch"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/PAS.0b013e31821ec4b5","article-title":"Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK\/T-cell lymphoma, nasal type, with EBV subtyping analysis","volume":"35","author":"Gualco","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<356::AID-IJC4>3.0.CO;2-D","article-title":"Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T\/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy","volume":"80","author":"Chiang","year":"1999","journal-title":"Int J Cancer"},{"key":"B112","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/030089160308900309","article-title":"Nasopharyngeal\/nasal type T\/NK lymphomas: analysis of 14 cases and review of the literature","volume":"89","author":"Garcia-Cosio","year":"2003","journal-title":"Tumori"},{"key":"B113","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11262-006-0008-5","article-title":"Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK\/T-cell lymphoma","volume":"34","author":"Nagamine","year":"2007","journal-title":"Virus Genes"},{"key":"B114","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0046-8177(99)90138-7","article-title":"High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue","volume":"30","author":"Dirnhofer","year":"1999","journal-title":"Human Pathol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1320-5463.2003.01552.x","article-title":"Comparative analysis of NK\/T-cell lymphoma and peripheral T-cell lymphoma in Korea: clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1","volume":"53","author":"Kim","year":"2003","journal-title":"Pathol Int"},{"key":"B116","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/leu.2013.212","article-title":"Quantification of circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance","volume":"28","author":"Kwong","year":"2014","journal-title":"Leukemia"},{"key":"B117","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/modpathol.2016.47","article-title":"Nasal-type NK\/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior","volume":"29","author":"Hong","year":"2016","journal-title":"Mod Pathol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"key":"B120","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10428199909050949","article-title":"Cytogenetic abnormalities in natural killer cell lymphoma\/leukaemia\u2013is there a consistent pattern?","volume":"34","author":"Wong","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"B121","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","article-title":"Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia","volume":"98","author":"Wong","year":"1997","journal-title":"Br J Haematol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","article-title":"Consistent patterns of allelic loss in natural killer cell lymphoma","volume":"157","author":"Siu","year":"2000","journal-title":"Am J Pathol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0002-9440(10)65454-5","article-title":"Comparative genomic hybridization analysis of natural killer cell lymphoma\/leukemia. Recognition of consistent patterns of genetic alterations","volume":"155","author":"Siu","year":"1999","journal-title":"Am J Pathol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"key":"B126","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"B129","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Hematopathology study group of the Korean Society of P. Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum Pathol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:35:29Z","timestamp":1694702129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":131,"alternative-id":["10.3389\/fped.2019.00071"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00071","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"article-number":"71"}}